source
- Tarsus to acquire eye-drug startup Alkeus in up to $800 million dealTarsus Pharmaceuticals announced Thursday that it will buy Alkeus Pharmaceuticals for up to $800 million, consisting of $270 million in cash and $180 million in stock. The agreement also provides…
- Tarsus Pharma to spend $450M upfront acquiring Alkeus to expand its ophthalmology pipelineTarsus Pharmaceuticals announced it will acquire Alkeus Pharmaceuticals, a Phase 3 biotech focused on a Stargardt disease drug, for an upfront payment of $450 million. The deal is intended to broad…